11.07.13
Phillips-Medisize Corp. has completed the facility expansion at its metal injection molding (MIM) plant on the company’s Menomonie, Wis., medical campus. This addition, according to company officials, was driven by new business in the medical device and commercial segments.
This capacity expansion focuses on metal injection molding business, which provides customers with complex, precision-shaped parts (150 grams or less in weight). The addition will increase the facility’s continuous debind and sintering furnace capability.
“The metal injection molding capability offers our customers a unique, cost-effective solution by providing complex shapes, superior strength, and dimensional precision in a scalable manufacturing model,” said Matt Jennings, Phillips-Medisize's president and CEO. “We have seen increased interest from our medical device customers to help them design for MIM in surgical device applications as they look for ways to reduce costs and improve quality versus machined parts. The facility’s expansion will bring much needed capacity to continue providing the highest level of satisfaction to our both our growing medical and commercial customers.”
Hudson, Wis.-based Phillips-Medisize provides design and manufacturing services to the medical device and diagnostics, drug delivery and commercial markets. The company has annual sales of more than $500 million with 75 percent of the total revenue coming from drug delivery, medical device and diagnostic products. The company employs more than 3,100 people in 19 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, and the Netherlands.
This capacity expansion focuses on metal injection molding business, which provides customers with complex, precision-shaped parts (150 grams or less in weight). The addition will increase the facility’s continuous debind and sintering furnace capability.
“The metal injection molding capability offers our customers a unique, cost-effective solution by providing complex shapes, superior strength, and dimensional precision in a scalable manufacturing model,” said Matt Jennings, Phillips-Medisize's president and CEO. “We have seen increased interest from our medical device customers to help them design for MIM in surgical device applications as they look for ways to reduce costs and improve quality versus machined parts. The facility’s expansion will bring much needed capacity to continue providing the highest level of satisfaction to our both our growing medical and commercial customers.”
Hudson, Wis.-based Phillips-Medisize provides design and manufacturing services to the medical device and diagnostics, drug delivery and commercial markets. The company has annual sales of more than $500 million with 75 percent of the total revenue coming from drug delivery, medical device and diagnostic products. The company employs more than 3,100 people in 19 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, and the Netherlands.